title: Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
authors.forename: D N
authors.initials: DN
authors.lastname: Lockwood
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000175:diagnosis / Q000188:drug therapy*; D008911:Minocycline / Q000627:therapeutic use*; D015242:Ofloxacin / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014944:World Health Organization
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004338:Drug Combinations; D007917:Leprostatic Agents; D015242:Ofloxacin; D008911:Minocycline; D012293:Rifampin